2024
|
Invention
|
An antibody-drug conjugate having two or more functional small molecule compounds for enhanced tr... |
2023
|
Invention
|
Targeted treatment of prostate cancers and other tumors by an antibody-drug conjugate. Provided h... |
|
Invention
|
A conjugate of a tubulysin analog with branched linkers.
Described is a conjugation of a tubulys... |
|
Invention
|
Conjugate of a tubulysin analog with branched linkers.
Described is a conjugation of a tubulysin... |
2022
|
Invention
|
Specific conjugation for an antibody-drug conjugate. Provided herein is a process for preparing a... |
|
Invention
|
Bcma monoclonal antibody and the antibody-drug conjugate. Provided is an antibody and an antibody... |
|
Invention
|
Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of mak... |
2021
|
Invention
|
Specific conjugation of an antibody. Provided herein is a process for preparing a homogeneous con... |
|
Invention
|
Conjugation of a cytotoxic drug with bis-linkage.
A conjugation of a cytotoxic drug to a cell-bi... |
|
Invention
|
Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such ... |
|
Invention
|
Conjugates of cell-binding molecules with cytotoxic agents. A conjugate of a potent cytotoxic age... |
2020
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparatio... |
|
P/S
|
Pharmaceutical preparations; chemico-pharmaceutical
preparations; drugs for medical purposes; ch... |
|
P/S
|
Pharmaceutical preparations, namely, for the treatment of cancers and immunological disorders, na... |
|
Invention
|
Conjugates of a cell-binding molecule with camptothecin analogs.
This invention relates to conju... |
|
Invention
|
Conjugates of a cell-binding molecule with camptothecin analogs. Provided are conjugates of campt... |
|
Invention
|
A formulation of a conjugate of a tubulysin analog to a cell-binding molecule.
A formulation of ... |
|
Invention
|
A formulation of a conjugate of a tubulysin analog to a cell-binding molecule. A formulation of c... |
|
Invention
|
Conjugates of cell binding molecules with cytotoxic agents. 13 are as defined herein, can be used... |
2019
|
Invention
|
Conjugates of tubulysin derivatives and cell binding molecules and methods of making.
The presen... |
|
Invention
|
Conjugates of tubulysin derivatives and cell binding molecules and methods of making. Involved is... |
|
Invention
|
Cell-binding molecule-tubulysin derivative conjugate and preparation method therefor. Involved is... |
|
Invention
|
A conjugate of a cytotoxic agent to a cell binding molecule with branched linkers.
The present i... |
|
Invention
|
A conjugate of a cytotoxic agent to a cell binding molecule with branched linkers. Provided is a ... |
|
Invention
|
A conjugate of an amanita toxin with branched linkers.
Provided herein is the conjugation of an ... |
|
Invention
|
A conjugate of an amanita toxin with branched linkers. Provided herein is the conjugation of an a... |
2018
|
Invention
|
A conjugation linker containing 2,3-diaminosuccinyl group.
The present invention relates to a co... |
|
Invention
|
Conjugation linkers containing 2,3-diaminosuccinyl group. Provided is a conjugate of a cytotoxic ... |
|
Invention
|
A cross-linked pyrrolobenzodiazepine dimer (pbd) derivative and its conjugates.
The present inve... |
|
Invention
|
Cross-linked pyrrolobenzodiazepine dimer (pbd) derivative and its conjugates. A novel cross-linke... |
2017
|
Invention
|
Conjugate of a tubulysin analog with branched linkers. The present invention relates to the conju... |
2016
|
Invention
|
Derivatives of amanita toxins and their conjugation to a cell binding molecule. 10, X, L, m, n an... |